Assembly Biosciences (ASMB) Revenue (2017 - 2026)
Assembly Biosciences' Revenue came in at $13.37 million for Q2 2026, up 38.9% from $9.63 million a year earlier and up 62.8% from the prior quarter.
Assembly Biosciences (ASMB) Revenue (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Assembly Biosciences reported Revenue of $74.85 million, up 125.1% year-over-year; for FY2025, it was $72.3 million, up 153.5% from FY2024.
- Revenue carries a five-year compound annual growth rate of -1.8% (FY2020 to FY2025).
- Going back by year, Revenue was $28.52 million in FY2024 (+298.2%), $7.16 million in FY2023 and $6.25 million in FY2021 (-92.1%).
- The five-year range for quarterly Revenue is $5.79 million (Q1 2024) to $42.47 million (Q4 2025).
- Year-over-year, Revenue increased in six of the last seven quarters, with growth averaging 91.3%.
- The fastest year-over-year change in Revenue over five years came in Q4 2025 (growth of 477.3%), and the weakest in Q3 2021 (a decline of 81.9%).
- Business Quant data shows ASMB's Revenue at $8.21 million (Q1 2026), $42.47 million (Q4 2025) and $10.79 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Assembly Biosciences | 466.09 Mn | -561.54 Mn | - | 13.37 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.37 Mn |
| Mar 31, 2026 | 8.21 Mn |
| Dec 31, 2025 | 42.47 Mn |
| Sep 30, 2025 | 10.79 Mn |
| Jun 30, 2025 | 9.63 Mn |
| Mar 31, 2025 | 9.42 Mn |
| Dec 31, 2024 | 7.36 Mn |
| Sep 30, 2024 | 6.85 Mn |
| Jun 30, 2024 | 8.53 Mn |
| Mar 31, 2024 | 5.79 Mn |
| Dec 31, 2023 | 7.16 Mn |
| Sep 30, 2021 | 6.25 Mn |
| Dec 31, 2020 | 1.04 Mn |
| Sep 30, 2020 | 34.61 Mn |
| Jun 30, 2020 | 39.38 Mn |
| Mar 31, 2020 | 4.08 Mn |
| Dec 31, 2019 | 4.77 Mn |
| Sep 30, 2019 | 4.23 Mn |
| Jun 30, 2019 | 3.08 Mn |
| Mar 31, 2019 | 3.89 Mn |
Assembly Biosciences Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ASMB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ASMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ASMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();